not only should these' patients be diagnosed and managed by an interdisciplinary group, but every effort should be made to treat all cases within the general orbit of this important national trial. Yours sincerely LIPMANN KESSEL (July, p 467) raises certain interesting points. While it remains unproven from this paper that patients with circulating malignant cells have a better prognosis than those patients in whom they are not demonstrated (the groups are unmatched, with significantly more A and B cases in the groups with circulating malignant cells) the thesis is attractive. If the number of circulating malignant cells is raised by giving fibrinolytic agents such as urokinase, would not the use of other methods to prevent thrombosis and platelet adhesion give similar results? With the great interest over the last few years in the prophylactic treatment to prevent deep vein thrombosis after many surgical procedures by the use of low-dose heparin or dextran infusion it would be pertinent to ask whether any of your readers have found a similar beneficial effect from these drugs, on the prognosis of both colorectal and other carcinomas.
It has also been suggested that protease and collagenase inhibitors such as aprotinin have a similar beneficial effect on reducing metastases in experimental animals. Yours faithfully P R HAWLEY 9 August 1976 A copy of Mr Hawley's letter was sent to Mr White and his co-authors and their reply appears below:
Dear Sir, We fully accept the statistical limitations in analysing our data and deliberately avoided suggesting a high degree of significance in such a small group with differing numbers of unmatched Dukes A, B and C cases -merely stating P values for the two main groups.
However, among the C cases (the most numerous group) it is worth noting that there was a 40 % survival when circulating malignant cells were present but only an 11% survival when malignant cells were not found. Our data were actually analysed as regards the overall survival at ten years in relation to the various states and as regards A, B and C classification within each group. The numbers involved are on the small side but when assessing the distribution of survival between categories A, B and C at ten years, there is a significant difference between dead and alive patients (P=0.5 %), with 'dead' showing excess C and shortfall in A and 'alive' the reverse.
There has been a great deal of experimental work with animal tumours suggesting that in certain systems anticoagulants and other agents such as ancrod (purified Malayan pit viper venom) can reduce metastases. The first clinical survey of patients on long-term anticoagulants which suggested a benefit was that by Michaels (1964, Lancet ii, 832) . Studies by Thornes (1972, Journal of the Irish Colleges of Physicians and Surgeons 2, 41) also suggested increased survival in cancer patients receiving anticoagulants. More recently Hoover & Ketcham (1976, personal communication) find an increased survival in anticoagulated patients undergoing operations for osteosarcoma.
All these trials are small and inconclusive. We agree that a retrospective analysis of survival in patients with malignant disease who have had low-dose heparin at the time of operative treatment would be interesting. We are starting a prospective trial of low-dose heparin and anticoagulants in patients with malignant disease. Yours Stage II carcinoma of the cervix gave rise to some hope that we might receive guidance on the management of this problem. In so far as treatment is concerned the papers as reported in the Proceedings (September, pp 673-686) are somewhat disappointing. Dr Cole advocates radium therapy alone for 'early' cases, Mr Feroze radiotherapy followed by surgery and Dr Baker varies her treatment with the histology and with the findings at preliminary lymphangiography. In each paper the results quoted are remarkably similar, particularly in IIA cases and we cannot judge from these reports what treatment should be employed.
If we are to choose the optimum treatment for the individual case we need much firmer evidence upon which to make the decision. Dr Baker's lymphangiographic findings of 40% involvement of iliac nodes in clinical Stage II cases may identify those in whom radium therapy alone is inadequatebut should surgery or external radiotherapy be relied upon to control extrauterine disease ? Is there evidence that intracavitary radium or cmesium can sterilize malignant spread to the parametria ? Does preoperative radium lead to an increased incidence of postoperative complications and is the incidence of bowel damage after radical pelvic radiotherapy unjustifiably high ? These and other questions remain unanswered and until they are, the treatment of Stage II carcinoma of the cervix will continue to depend on the personal opinion of the clinician to whom the patient is referred. Yours faithfully ROBERT J DICKSON 2 September 1976 Offshore Medicine From Surgeon Vice-Admiral Sir James Watt Medical Director-General (Naval), Ministry ofDefence, Empress State Building, London SW6 I TR Dear Sir, You generously devoted considerable space to a comprehensive review of the current status of offshore medicine (August Proceedings, p 583) which highlighted the consequences of exploitation of natural resources in the absence of a coherent medical policy. It is to the credit of the Scottish Home and Health Department that it has attempted to meet this need by identifying available medical expertise and coordinating the interests of the various authorities with a view to solving the very considerable problems that continue to make North Sea diving a high-risk occupation.
It is suggested that divers are accident-prone and this is clearly one of the factors requiring elucidation in any prospective study of the epidemiology of diving accidents, but the difficulty of obtaining accurate mortality and morbidity statistics merely underlines the prior need for a central data bank. That discipline may be a factor is inferred from Elliott's statement (p 591) that the incidence of aseptic bone necrosis in naval divers is only 5 % compared with up to 50 % in civilian divers.
While an effective organization has now been evolved for dealing with a local rig accident or major disaster, if lives are to be saved and injuries minimized, vigorous action is needed to provide a recognized training programme and approved qualification for the 'rig medic' who is the key figure in accident prevention and initial casualty management, a procedure complicated by the difficulty of bringing an injured diver safely inboard. I should ther-efore like to reinforce the plea for first-aid training of rig personnel, bearing in mind the frightening possibilities outlined by Oliver (p 596).
Any significant extension of saturation diving will sooner or later involve the treatment of a diver isolated for days in his hyperbaric environment. The consequent problem of transfer under pressure for prolonged treatment by a highly specialized medical or surgical team in a larger hyperbaric facility will then arise. Unless there is early agreement on the provision, design and standardization of suitable chambers for transfer and therapy, it is difficult to believe that tragedies can be averted.
Finally, the considerable research effort required to identify the causes and mechanisms of injury has been repeatedly emphasized. It is likely to be both costly and time-consuming and should therefore involve the active collaboration of all scientists, doctors and engineers engaged in this field and draw heavily upon Service experience. Happily, as Admiral Rawlins has indicated (p 583), the prospect of that collaboration is now in sight. Yours faithfully JAMES WATr
